Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

24.43
+0.08000.33%
Post-market: 24.620.1900+0.78%16:34 EDT
Volume:511.72K
Turnover:12.56M
Market Cap:1.68B
PE:-10.17
High:25.17
Open:24.80
Low:24.27
Close:24.35
52wk High:40.65
52wk Low:12.12
Shares:68.76M
Float Shares:44.33M
Volume Ratio:0.31
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4031
EPS(LYR):-2.0125
ROE:-45.31%
ROA:-28.46%
PB:4.75
PE(LYR):-12.14

Loading ...

Is Tyra Biosciences’ (TYRA) Dabogratinib 3×3 Focus Reframing Its Risk Reward Profile?

Simply Wall St.
·
May 16

Jefferies Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)

TIPRANKS
·
May 14

Bank of America Securities Keeps Their Buy Rating on Tyra Bioscience (TYRA)

TIPRANKS
·
May 14

Tyra Biosciences Price Target Maintained With a $45.00/Share by HC Wainwright & Co.

Dow Jones
·
May 14

Tyra Bioscience (TYRA) Gets a Buy from Barclays

TIPRANKS
·
May 14

Tyra Biosciences reports Q1 EPS (64c), consensus (59c)

TIPRANKS
·
May 14

Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (WST), CalciMedica (CALC) and Tyra Bioscience (TYRA)

TIPRANKS
·
May 13

Earnings Flash (TYRA) Tyra Biosciences Posts Q1 Net Loss $0.64 a Share, vs. FactSet Est of $0.59 Loss

MT Newswires Live
·
May 13

Tyra Biosciences Q1 EPS $(0.64) Misses $(0.59) Estimate

Benzinga Earnings
·
May 13

Tyra Biosciences Q1 FY26 net loss widens to $39.31 million

Reuters
·
May 13

Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

THOMSON REUTERS
·
May 13

Tyra Biosciences Inc: Cash, Cash Equivalents and Marketable Securities of $383.5 Mln at Q1 2026; Runway Into 2H 2028

THOMSON REUTERS
·
May 13

Tyra Biosciences Q1 EPS USD -0.64

THOMSON REUTERS
·
May 13

Tyra Biosciences Q1 Operating Expenses USD 41.998 Million

THOMSON REUTERS
·
May 13

Tyra Biosciences to present at BofA Securities Health Care Conference

Reuters
·
May 08

How TYRA-300 Bladder Cancer Data and New Trial Partnership Will Impact Tyra Biosciences (TYRA) Investors

Simply Wall St.
·
May 06

Does Tyra Biosciences (TYRA) Board Refresh and Dabogratinib Spotlight Reframe Its Pipeline Credibility?

Simply Wall St.
·
Apr 27

Tyra Biosciences director Habib J. Dable files initial beneficial ownership statement

Reuters
·
Apr 21

Tyra Biosciences announces annual shareholder meeting via webcast

Reuters
·
Apr 17

Tyra Biosciences appoints Habib Dable to board of directors

Reuters
·
Apr 17